Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Filter
News
Articles
Podcasts
Infographics
AZ’s Stefan Woxström on preparing healthcare systems for the future
Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca, talks about the need for future-proofing healthcare systems, incentivising innovation and reimbursement.
Read more
The metrics of medical affairs
Measuring the impact of medical affairs is less straightforward than it is for R&D or commercial, but we must establish success metrics.
Creating brand loyalty with RWE
The commercial value of RWE is yet to be realised, but the benefits extend far beyond the aisles in which it is currently in high demand.
Calling checkmate on meaningless social media
The pharma industry is dabbling in the game of social media, and it’s no secret that they need to have a better presence on these platforms.
Digital therapeutics: fad or force for change?
More and more digital therapeutics are hitting the market, taking the patient experience of healthcare into a more innovative, less invasive place, but are these digital devices worth the hype?
Best supporting role: patient organisations
In pharma’s bid to be patient centric, it must bring the patient voice to the drug development process with the help of medical affairs.
Integrating wellness into pharma's patient approach
The transition from reactive to proactive treatments correlates with society’s new-found focus on well-being, and the pharma industry must embrace wellness and adapt to steamroll this into improved overall outcomes for patients.
Patient Data: Opting In or Out?
At one point in time, our world’s most valuable commodity was oil. Fast forward to the digital age and that accolade is held by data. Free-flowing rivers of it double up as life sources that all industries, including the pharmaceutical industry, have become dependent on. However, as consumers learn the true value of their own information, the broken dam of data is patched up with privacy laws.
Does pharma need more 'social' leaders?
Pharmaceutical companies have embraced the corporate social media account, but many lack the personal touch of a profile run by their leader. The opportunity to connect with employees and patients alike is unbounded; the time to log on is now.
Loading posts...
« Previous
1
…
23
24
25
26
27
…
29
Next »